https://lv.prisysbiotech.com/ Nav - Cilvēks Primāts Pētījumi Platforma & CRO | PRISYS Biotehnoloģijas https://lv.prisysbiotech.com/uploads/39406/logo.png https://lv.prisysbiotech.com/safety-evaluation/ Drošības novērtējums https://lv.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://lv.prisysbiotech.com/nhp-pharmacology/ NHP farmakoloģija https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/translation-research/ Tulkošanas pētījumi https://lv.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://lv.prisysbiotech.com/biosafety-research/ Bioloģiskās drošības pētījumi https://lv.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://lv.prisysbiotech.com/pk-pd-adme/ PK+PD+ADME https://lv.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://lv.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://lv.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://lv.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://lv.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://lv.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://lv.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://lv.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://lv.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://lv.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://lv.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://lv.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://lv.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://lv.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://lv.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://lv.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://lv.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://lv.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://lv.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://lv.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://lv.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://lv.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://lv.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://lv.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://lv.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://lv.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://lv.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://lv.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://lv.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://lv.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://lv.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://lv.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://lv.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://lv.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://lv.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://lv.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://lv.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://lv.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://lv.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://lv.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://lv.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://lv.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://lv.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://lv.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://lv.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://lv.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://lv.prisysbiotech.com/pk-pd-adme/adme.html ADME https://lv.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://lv.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://lv.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://lv.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://lv.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://lv.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://lv.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://lv.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://lv.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://lv.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://lv.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://lv.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://lv.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://lv.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://lv.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://lv.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://lv.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://lv.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://lv.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://lv.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://lv.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://lv.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://lv.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://lv.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://lv.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://lv.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://lv.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://lv.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://lv.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://lv.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://lv.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://lv.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://lv.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://lv.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://lv.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://lv.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://lv.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://lv.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://lv.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://lv.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://lv.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://lv.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://lv.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://lv.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://lv.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://lv.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://lv.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://lv.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://lv.prisysbiotech.com/translation-research/clinical-imaging.html Klīniskā attēlveidošana https://lv.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Klīniskā attēlveidošana https://lv.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://lv.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://lv.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://lv.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://lv.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://lv.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://lv.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://lv.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://lv.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://lv.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://lv.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://lv.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://lv.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://lv.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://lv.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://lv.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2. tipa cukura diabēta modelis https://lv.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png 2. tipa cukura diabēta modelis https://lv.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://lv.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://lv.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://lv.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://lv.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://lv.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://lv.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://lv.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://lv.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://lv.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://lv.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://lv.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://lv.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://lv.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://lv.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://lv.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://lv.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://lv.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://lv.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://lv.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://lv.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://lv.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://lv.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://lv.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://lv.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://lv.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://lv.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://lv.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://lv.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://lv.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://lv.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://lv.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://lv.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://lv.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://lv.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://lv.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://lv.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://lv.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://lv.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://lv.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://lv.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://lv.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://lv.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://lv.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://lv.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://lv.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://lv.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://lv.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://lv.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://lv.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://lv.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://lv.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://lv.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://lv.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://lv.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://lv.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://lv.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://lv.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://lv.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://lv.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://lv.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://lv.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://lv.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003151440143360.html Molekulārā attēlveidošana NHP modeļos zāļu tulkošanai https://lv.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://lv.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17969424078906368.html NHP BehaviorAtlas tīmekļa seminārs|3D NHP uzvedības izsekošana zāļu attīstībai https://lv.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://lv.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724261183005696.html 2025. gada kopsavilkums: Kā Prisys no jauna definē tulkošanas uzticamību NHP izpētē https://lv.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://lv.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17558093692085248.html NHP - balstīta farmakoloģija un farmakodinamiskie pakalpojumi|Prisys biotehnika https://lv.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://lv.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530132813079552.html Iepazīstieties ar Prisys biotehnoloģiju gaidāmajā ES Roadshow: 2025. gada septembris https://lv.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://lv.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17448327963042816.html Prisys Biotech-2025. gada vidējā pārskats https://lv.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://lv.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243113120670720.html Iepazīstieties ar Prisys gaidāmajā ASV-Roadshow 2025. gada martā https://lv.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://lv.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83977666.html PRISYS 2024. gada pārskats: NHP modeļu un preklīnisko pētījumu attīstība https://lv.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://lv.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77736615.html Prisys Biotech 2024. gada 2. ceturkšņa biļetens — uzlabota pirmsklīniskā pētniecība un izstrāde CNS terapijai ar PRISYS krusteniski reaģējošiem modeļiem https://lv.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://lv.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028056021984256.html Kāpēc dzīvnieku modeļi gūst panākumus vai neveiksmes zāļu izstrādē https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021142681248768.html Kvantitatīvā PET mērķa iesaistīšanās NHP attiecībā uz CNS zālēm https://lv.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://lv.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015123856172032.html No video līdz datiem: 3D AI izsekošana NHP uzvedībai https://lv.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://lv.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015225177940992.html PET bioloģiskās izkliedes attēlveidošana primātiem, kas nav{0}}cilvēki https://lv.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://lv.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003151345853440.html PBPK vs. Nodalījumu modeļi: kāpēc PBPK ir svarīgi https://lv.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://lv.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993068202058752.html Tīmekļsemināra kopsavilkums: NHP tulkošanas izpētes veicināšana, izmantojot digitālās uzvedības fenotipēšanu https://lv.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://lv.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990351501452288.html PK biomarķieri preklīniskajā zāļu izstrādē|Iedarbība — reakcija un PK/PD https://lv.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://lv.prisysbiotech.com/news/behavior-in-rhesus-17984977101038592.html Spontāna pašdarbība-savainojoša uzvedība rēzus makakos: NHP translācijas modelis neiropsihiatrisko zāļu izstrādei https://lv.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://lv.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17984976334332928.html MIDD un NHP efektivitātes modeļi translācijas zāļu izstrādē https://lv.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://lv.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17976200764351488.html AI-3D NHP uzvedības analīze|Bezmarķieru uzvedības fenotipēšana https://lv.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://lv.prisysbiotech.com/news/webinar-nhp-behavioratlas-17976183786841088.html Globālais vebinārs|Sarežģītas NHP uzvedības kvantitatīva noteikšana: NHP uzvedības atlanta ieviešana augstas{0}}3D uzvedības fenotipu noteikšanai https://lv.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://lv.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17969424438027264.html AI-Spēcīga NHP uzvedības analīze preklīniskai zāļu izstrādei|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://lv.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17976199324247040.html Kad ieviest NHP pētījumus autoimūno zāļu izstrādē https://lv.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://lv.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17976194285069312.html NHP IBD modeļi: ko hronisks enterokolīts rēzus makakos mums māca par zarnu trakta iekaisumu https://lv.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://lv.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17976186453976064.html MRI-Vadīta AAV piegāde NHP smadzeņu modeļos CNS gēnu terapijai https://lv.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://lv.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17976201010406400.html Kāpēc pozitīvas kontroles zāles ir svarīgas autoimūno slimību modeļos|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://lv.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17976181418779648.html Sākotnējais ADA skrīnings izskalotajiem{0}}pērtiķiem preklīniskajiem bioloģiskajiem pētījumiem https://lv.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://lv.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17969424082199552.html Sāpju mehānismi: UVB saules apdeguma modelis ir būtisks tulkošanas rīks https://lv.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://lv.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17969424108938240.html Mātes augsta{0}}tauku diētas un bērnu aptaukošanās programmu NHP modeļi https://lv.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://lv.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17942330905486336.html Klīniskās patoloģijas interpretācija suņiem un primātiem, kas nav cilvēkveidīgie primāti preklīniskajos pētījumos https://lv.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://lv.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17942331977327616.html Molekulārās attēlveidošanas biomarķieri: tulkošanas pētniecības un zāļu izstrādes veicināšana https://lv.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://lv.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17942332048057344.html Kas ir nelineārā farmakokinētika? Mehānismi, īpašības un ietekme uz zāļu izstrādi https://lv.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://lv.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17942332393137152.html Kāpēc NHP molekulārā attēlveidošana ir būtiska translācijas PET pētījumiem? https://lv.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://lv.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17942332591498240.html Kas ir molekulārā attēlveidošana un kāpēc tā ir svarīga zāļu izstrādē? https://lv.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://lv.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17942333015368704.html NHP radionuklīdu bioloģiskās izkliedes pētījumi: molekulārā attēlveidošana zāļu tulkošanai https://lv.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://lv.prisysbiotech.com/news/nhp-heart-failure-model-17942331875156992.html NHP sirds mazspējas modelis atbalsta translācijas pētījumus par telomēru atjaunošanas gēnu terapiju https://lv.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://lv.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17942332422349824.html Kā DSA un CTA attēlveidošana uzlabo kardiovaskulāro zāļu drošības novērtējumu https://lv.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://lv.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17942331804738560.html NHP arteriovenozās šunta trombozes modelis Cynomolgus pērtiķiem translācijas antitrombotisku zāļu novērtēšanai https://lv.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://lv.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888507957617664.html Farmakokinētiskie dati kā translācijas biomarķieris https://lv.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://lv.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888508164482048.html Plaušu fibrozes modeļi, kas nav{0}}cilvēku primāti: translācijas precizitātes uzlabošana elpošanas ceļu zāļu izstrādē https://lv.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://lv.prisysbiotech.com/news/nhp-models-translational-drug-development-17888507922260992.html Kāpēc zāļu izstrāde arvien vairāk ir atkarīga no NHP modeļiem|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://lv.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888508413780992.html PK dati kā farmakodinamisks biomarķieris: zāļu translācijas attīstības veicināšana, izmantojot kvantitatīvo farmakoloģiju https://lv.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://lv.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17854928353436672.html Ne--GLP farmakoloģijas pētījumi regulatīvai iesniegšanai: datu integritāte un laboratorijas prasības https://lv.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://lv.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17854940250153984.html Neklīnisko farmakokinētisko pētījumu stratēģiskais dizains: no ADME profilēšanas līdz translācijas lēmuma pieņemšanai{0}} https://lv.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://lv.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17854927868781568.html NHP AV-Šunta trombozes modelis zāļu drošības novērtēšanai|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://lv.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17854928091980800.html Kas ir nelineārā farmakokinētika? Mehānismi un tulkošanas PK novērtējums|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://lv.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17854927800001536.html Prisys Biotech atbalsta FDA un CDE IND apstiprinājumu UX-GIP001|NHP CNS piegādes platforma https://img01.v15cdn.com/gallery/4x3/157.webp https://lv.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17854927831458816.html In vivo imūno šūnu izsekošana un PET marķiera izstrāde NHP modeļos|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://lv.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17854927835472896.html Dopamīna transportētāja PET attēlveidošana NHP modeļos|CNS attēlveidošana|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://lv.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17854927802557440.html PET/CT bioloģiskā sadale NHP modeļos CNS zāļu piegādei|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://lv.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17854927782667264.html Liela-dzīvnieku radioaktīvo marķēšanas un in vivo attēlveidošanas platforma zāļu tulkošanai https://lv.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://lv.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17854927779783680.html Kāpēc zāļu izstrāde arvien vairāk balstās uz NHP modeļiem: primātu būtiskā loma tulkošanas medicīnā|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://lv.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17854927735333888.html IPF zāļu izstrādes izaicinājumi un risinājumi|NHP modeļi ar CT attēlveidošanu un PFT https://lv.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://lv.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17854927689262080.html AI bezmarķiera NHP 3D uzvedības analīzes sistēma preklīniskiem pētījumiem https://lv.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://lv.prisysbiotech.com/news/evaluating-dmpk-properties-17854927758484480.html Kandidātsavienojumu DMPK īpašību novērtēšana agrīnā zāļu atklāšanā|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://lv.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17854927836668928.html MRI-CNS piegāde ar vadību NHP modeļos|Tulkošanas IMRI un CED platforma https://lv.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://lv.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17854927827477504.html NHP CNS bioloģiskās izkliedes pētījumi|Intratekāla RNS piegāde|PRISYS Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://lv.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17854928167199744.html Translation PK/PD Framework: Cynomolgus Monkey to Human Dose Prediction|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://lv.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724262014198784.html Kad sāpes kļūst par atmiņu: hronisku sāpju emocionālie virzītāji un NHP modeļa priekšrocības|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://lv.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724261283898368.html Vairāku-beigu punktu sāpju novērtējums: pretsāpju zāļu izstrādes nākotne https://lv.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://lv.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724261219689472.html Kāpēc tik daudzi pretsāpju līdzekļi neizdodas preklīniskajos pētījumos? Atbilde ir, kā mēs novērtējam sāpes https://lv.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://lv.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724261284701184.html Asins paraugu ņemšanas laika punktu plānošana farmakokinētikas (PK) pētījumos|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://lv.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724261272200192.html PK statistika: ne{0}}nodalījuma analīzes (NCA) parametri un preklīniskie pielietojumi https://lv.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://lv.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724261225112576.html Kāpēc primātu modeļi, kas nav{0}}cilvēku primāti, ir ļoti svarīgi CNS oligonukleotīdu terapijai https://lv.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://lv.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724268926329856.html Urīnskābes metabolisms cilvēkiem pret pērtiķiem: translācijas ietekme uz zāļu attīstību https://lv.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://lv.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724261955249152.html Ne-Cilvēka primātu MASH-saistītais aknu fibrozes modelis|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://lv.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724261265761280.html Kāpēc IMRI{0}}vadīta smadzeņu zāļu piegāde ir būtiska precīzai mērķauditorijas atlasei NHP pētījumos https://lv.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://lv.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674693527528448.html AI-Bezmarķieru vadīta NHP 3D uzvedības analīzes sistēma|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://lv.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674688167093248.html LPS-Inducēta akūta plaušu iekaisuma (ALI) NHP modelis|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://lv.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674688056681472.html HDM+SEB-Inducēta atopiskā dermatīta (ATD) modelis Cynomolgus Monkeys https://lv.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://lv.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674705814627328.html Viena- līdz vairāku-nodalījumu PK modeļu skaidrojums|NHP farmakokinētika|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://lv.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674693676000256.html Kā izvēlēties uzticamu pirmsklīnisko CRO|Galvenie kritēriji biotehnoloģiju uzņēmumiem|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://lv.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674714891330560.html Tulkošanas CAR-T novērtējums: In Vitro ekspertīze un NHP studiju atbalsts — Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://lv.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674688043623424.html Kāpēc vairāk nekā 90% CNS zāļu kandidātu klīniskajos pētījumos neizdodas? https://lv.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://lv.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674688321758208.html Parkinsona slimības preklīniskie modeļi: ceļvedis neirotoksīnu, ģenētisko un NHP modeļu izvēlei|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://lv.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674699965719552.html Augstas-precīzas zāļu piegādes un AI-vadītas NHP tulkošanas platformas https://lv.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://lv.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625277173392384.html Th17 vadīti NHP imunoloģijas modeļi|Translācijas autoimūnie pētījumi uzņēmumā Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://lv.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625277353518080.html AI-Pamatota NHP BehaviorAtlas® sistēma|3D uzvedības analīzes platforma|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://lv.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625277319619584.html RFP veidne NHP pētījumiem|Paātrināt pirmsklīnisko pētījumu efektivitāti https://lv.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://lv.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625277152437248.html Cold Allodynia Pain Model in Cynomolgus Monkeys|Prisys biotehnoloģijas https://lv.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://lv.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625277414908928.html MRI{0}}Vadīta intracerebrāla zāļu piegādes platforma|Prisys Biotech CNS izpēte https://lv.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://lv.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625277516915712.html NHP elpceļu slimību modeļi un elpceļu zāļu piegādes platforma|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://lv.prisysbiotech.com/news/nhp-renal-biopsy-17625277505807360.html NHP nieru biopsijas platformas un nieru slimību modeļi|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/276.webp https://lv.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625277423084544.html PK pētījumi un mērķtiecīga zāļu piegāde|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://lv.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625277202883584.html Prisys Biotechnologies NHP izpētes un AI{0}}uzvedības analīzes platforma https://lv.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://lv.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625277147833344.html No deguna-uz-smadzenēm (N2B) piegādes tehnoloģija CNS pētījumiem|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://lv.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625277067469824.html SHR-2004: Izrāviens VTE profilaksē olnīcu vēža slimniekiem — Prisys Biotech veiksmes stāsts https://lv.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://lv.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538436296303616.html Cynomolgus & Rhesus pērtiķu modeļi|Prisys Biotech Preklīniskais CRO https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530132643177472.html Idiopātiskā plaušu fibroze (IPF) NHP modelis|Prisys Biotech Preklīniskais CRO https://lv.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://lv.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530132579001344.html Cynomolgus pērtiķu bioloģiskās izplatības pētījumi|Prisys Biotech Preklīniskais CRO https://lv.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://lv.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530132706255872.html Prisys Biotech NHP modeļi hematoloģijai un insulta pētījumiem https://lv.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://lv.prisysbiotech.com/news/the-importance-of-administration-volume-17530132536632320.html Administrācijas apjoma nozīme preklīniskajos pētījumos|Prisys biotehnika https://lv.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://lv.prisysbiotech.com/news/brain-targeted-drug-delivery-17530132577018880.html Smadzenes - mērķtiecīga zāļu piegāde|Prisys Biotech preklīniskie NHP pētījumi https://lv.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://lv.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530132451501056.html ADC zāļu izstrāde|Translācijas PK/PD ietvars preklīniskajos NHP pētījumos https://lv.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://lv.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17497383784408064.html NHP sāpju modeļi translācijas narkotiku atklāšanai|Prisys biotehnika https://lv.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://lv.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17497383627138048.html Serums vs. Plazma: optimālās matricas izvēle preklīniskajai bioanalīzei https://lv.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://lv.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17497383620092928.html Preklīniskās dozēšanas vadlīnijas: IV un PO tilpums, PH un osmolaritāte precīzai PK NHP un citām sugām https://lv.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://lv.prisysbiotech.com/news/nhp-copd-model-17497383740302336.html Prisys augstākie HOPS pētījumu modeļi un elpošanas platformas izcilība https://lv.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://lv.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17497383646651392.html NHP akūta asiņošanas modelis: būtisks līdzeklis jaunas hematoloģijas zāļu attīstības paātrināšanai https://lv.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://lv.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17497383660987392.html Pruritus Research: Prisys Biotech IL-31 izraisīts NHP modelis anti-etit terapijas novērtēšanai https://lv.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://lv.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17448327444898816.html Rokasgrāmata pret{0}}zāļu antivielu (ADA) novērtēšanai https://img01.v15cdn.com/gallery/4x3/148.webp https://lv.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17448327430759424.html Elpošanas terapija: Prisys Biotech integrētā NHP platforma pirmsklīniskajiem pētījumiem https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17448327484417024.html NHP sāpju modeļi: pretsāpju līdzekļu zāļu izstrāde Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://lv.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17448327404938240.html NHP modeļa platformas, lai atbalstītu zāļu attīstību sarežģītās slimībās https://lv.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://lv.prisysbiotech.com/news/key-considerations-for-dosing-volume-17448327514383360.html Galvenie apsvērumi attiecībā uz dozēšanas tilpumu, PH un formulu dzīvnieku modeļos https://lv.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://lv.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17448364204057600.html Inženierijas eksosomas: revolucionāra zāļu piegāde CNS traucējumiem — Prisys Biotech preklīniskie ieskati https://img01.v15cdn.com/gallery/4x3/300.webp https://lv.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17448327284614144.html Dzīvnieku sugu atlases pamatprincipi nukleīnskābju zāļu toksikoloģijas pētījumos https://img01.v15cdn.com/gallery/4x3/148.webp https://lv.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17448364807939072.html Prisys Biotech DSA un IMRI hematoloģiskiem, asinsvadu un nieru slimību pētījumiem https://lv.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://lv.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17448327407559680.html Cynomolgus pērtiķu sāpju modeļi: Translācijas pētījumu stimulēšana revolucionārai jonu kanālu terapijai https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17448327418602496.html Atopiskā dermatīta pētījumu uzlabošana: Prisys Biotech primātu (NHP) modelis, kas nav cilvēkveidīgais primāts (NHP) https://lv.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://lv.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17448327319757824.html Prisys Biotech NHP atopiskā dermatīta modelis anti-prurītu zāļu izstrādei https://lv.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://lv.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374207012480000.html Dzīvnieku pētījumu plānošana: galvenie apsvērumi, lai gūtu panākumus pirmsklīniskajos pētījumos https://img01.v15cdn.com/gallery/4x3/300.webp https://lv.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374206876689408.html Atopiskais dermatīts: kā Cynomolgus pērtiķu modeļi veicina precizitātes terapiju https://lv.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://lv.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374206793966592.html Astmas pētījumi: kāpēc{0}}primātu modeļiem, kas nav cilvēkveidīgie primāti, ir izšķiroša nozīme jaunu zāļu izstrādē https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374206697858048.html Izpratne par antisensu oligonukleotīdu (ASO) farmakokinētiku: galvenie absorbcijas un izkliedes faktori https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374285950477312.html NHP inhalācijas pētījumi bioloģiskiem līdzekļiem: PRISYS specializētie pirmsklīniskie CRO pakalpojumi https://img01.v15cdn.com/gallery/4x3/300.webp https://lv.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374206788592640.html Uzlaboti pirmsklīniskie inhalācijas pētījumi: tehniskās iespējas un zināšanas uzņēmumā Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://lv.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374206644577280.html Izpratne par farmakokinētiku (PK): galvenie parametri un lietojumi zāļu izstrādē https://lv.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://lv.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374206811612160.html Intracerebroventrikulāra (ICV) injekcija: precīza CNS ievadīšana preklīniskiem pētījumiem https://lv.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://lv.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374206733558784.html Intracerebrāla (ICM) injekcija: precīza mērķa noteikšana CNS terapijai — preklīniskie apsvērumi https://img01.v15cdn.com/gallery/4x3/148.webp https://lv.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374206719271936.html Intratekāla (IT) injekcija: tiešs CNS ievadīšanas ceļš uzlabotajām terapijām — preklīniskie apsvērumi https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374206714799104.html Parkinsona slimības izpētes veicināšana, izmantojot NHP modeli https://img01.v15cdn.com/gallery/4x3/300.webp https://lv.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374206940881920.html Preklīniskie PK/PD pētījumi un NHP modeļi zāļu izstrādei|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://lv.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298358447023104.html Interleikīna-31 (IL-31) mērķauditorijas atlase: jauna robeža autoimūno slimību zāļu izstrādē — Prisys Biotech NHP modeļi pirmsklīniskajiem pētījumiem https://lv.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://lv.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295212356985856.html Neklīnisks imūntoksicitātes novērtējums: stratēģija, galvenie apsvērumi un metodes izvēle https://img01.v15cdn.com/gallery/4x3/232.webp https://lv.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295211942503424.html Mikrobu testēšana un tās ietekme uz primātiem, kas nav{0}}cilvēki primāti DMPK preklīniskajos pētījumos https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295249729889280.html Cynomolgus pērtiķu endometriozes modelis terapeitisko pētījumu uzlabošanai https://lv.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://lv.prisysbiotech.com/news/membranous-nephropathy-model-17295178782991360.html Membrānas nefropātijas (MN) zāļu izstrāde: Prisys Biotech Cynomolgus Monkey modeļu platforma https://img01.v15cdn.com/gallery/4x3/148.webp https://lv.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295178982745088.html Inhalējamo zāļu farmakokinētika: paradigmas maiņa no sistēmiskas iedarbības uz plaušām https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/animal-models-for-womens-health-17295178857767936.html Prisys Biotech: dzīvnieku modeļi sieviešu veselības terapijai https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295212315321344.html Pasaules aptaukošanās diena|Prisys Biotech NHP metabolisma modeļi: nākamās paaudzes novēršanas terapijas attīstības darbība https://lv.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://lv.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295178837566464.html Prisys Biotech Cynomolgus pērtiķu psoriāzes modelis: preklīniskās farmakodinamikas novērtēšanas uzlabošana https://lv.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://lv.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295178763281408.html Farmakokinētikas un farmakodinamikas integrācija zāļu izstrādē https://lv.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://lv.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888507864015872.html Tīmekļseminārs pēc-pieprasījuma|Precīzijas tilts: MRI{1}}CED un tulkojami NHP modeļi CNS zāļu piegādei https://lv.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://lv.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295178967917568.html Ko īsti apstiprina koncepcijas pierādījums (PoC) zāļu izstrādē? https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295178701513728.html Dzīvnieku modeļi|Izaicinājumi un pielietojumi sāpju modeļu izstrādē https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295179159806976.html Neklīniskie farmakodinamiskie pētījumi https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243113703171072.html Ideālā primāta, kas nav{0}}cilvēks primāts toksikoloģijas pētījumiem: makaka makaka, rēzus makaka un marmoze https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81183243.html Mērķtiecīga Parkinsona slimības terapija: izrāviens reāllaika-MRI-vadītā cilmes šūnu transplantācijā https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295178713654272.html Sistēmiskā sarkanā vilkēde (SLE) un dzīvnieku modeļu loma terapeitiskajā attīstībā https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295178854163456.html Reimatoīdā artrīta (RA) primātu modelis (RA) https://lv.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://lv.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295178704315392.html Dzīvnieku smadzeņu stereotaktiskie instrumenti, kuru pamatā ir 3D koordinātu sistēmas https://lv.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://lv.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295179068285952.html Dzīvnieku modeļi in vivo testēšanai (1): izveide un klasifikācija https://img01.v15cdn.com/gallery/4x3/148.webp https://lv.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83978468.html Izpētiet iespējamos ceļus, kā bioloģiskās vielas iekļūt smadzenēs https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83977660.html Reimatoīdā artrīta (RA) izpētes veicināšana ar primātu modeļiem, kas nav cilvēkveidīgie primāti https://lv.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://lv.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83977645.html Dzīvnieku modeļu izpēte atopiskā dermatīta zāļu efektivitātei https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83977657.html Dzīvnieku modeļu kritiskā loma cilvēku slimību izpētē https://lv.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://lv.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83977648.html Parkin gēnu deficīta pērtiķu modelis atklāj jaunus Parkinsona slimības mehānismus un terapeitiskos mērķus https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83977654.html Neklīniskas zāļu izstrādes rokasgrāmata: akūtas, subakūtas, subhroniskas un hroniskas vispārējās toksicitātes pētījumi https://lv.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://lv.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83977710.html Inovatīvu zāļu ievadīšana no deguna līdz smadzenēm (N2B): asins-smadzeņu barjeras apiešana https://lv.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://lv.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83977640.html Minicūku kā neklīniskas lielo dzīvnieku sugas iespējas un izaicinājumi https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83035267.html Zāļu piegādes stratēģijas smadzeņu slimībām https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83054902.html Reāllaika-Intraoperatīva MRI navigācija: FDA apstiprinājuma atbalstīšana pirmajai gēnu terapijai AADC deficīta gadījumā https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83033372.html Acu pilienu acu toksicitātes pētījumi: zāļu iedarbības un drošības novērtējums https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82725685.html Prisys Biotech izveido Cynomolgus pērtiķu psoriāzes modeli, lai paātrinātu zāļu izstrādi https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82725682.html Visaptveroši primātu modeļi, kas nav{0}}cilvēku primāti nieru slimību izpētei, Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82725677.html Antivielu{0}}konjugātu (ADC) visaptverošs preklīniskais drošības novērtējums primātiem, kas nav cilvēkveidīgie primāti https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82726273.html Antivielu{0}}narkotiku konjugātu (ADC) farmakokinētikas novērtējums primātiem, kas nav cilvēkprimāti https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82725675.html ADC farmakodinamikas novērtējums https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82725678.html Izpratne par ADC narkotiku DMPK https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82725687.html Progress nukleīnskābju zāļu un Prisys Biotech pētniecības iespēju attīstībā https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395268.html MRNS plaušu piegādes sistēmu un Prisys biotech novatorisko pakalpojumu attīstība https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82725690.html Kāpēc 2024. gada Nobela prēmija fizioloģijā vai medicīnā tika piešķirta šiem diviem zinātniekiem, kuri pētīja mikroRNS? https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82725676.html Farmakokinētiskie (PK) apsvērumi attiecībā uz centrālās nervu sistēmas (CNS) zālēm https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656491.html Sasniegumi CNS izpētē: Prisys Biotech MRI{0}}saderīgā smadzeņu injekcijas sistēma un CED tehnoloģija https://lv.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://lv.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81182747.html Asiņošanas un recēšanas terapijas jauninājumi ar Cynomolgus Monkey MCAO modeli https://lv.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://lv.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81182745.html DMPK centrālās nervu sistēmas (CNS) zāļu novērtējums https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/animal-models-of-human-diseases-81182742.html Cilvēku slimību dzīvnieku modeļi https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81182738.html Inovācijas sāpju novērtēšanā: AI-vadīta uzvedības analīze https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/china-experimental-monkey-industry-81182739.html Ķīnas eksperimentālās pērtiķu nozares vēsture, pašreizējais stāvoklis, izaicinājumi un iespējas https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/human-disease-animal-models-81182743.html Cilvēku slimību dzīvnieku modeļi: būtisks instruments biomedicīnas pētījumu veicināšanai https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81182737.html Preklīniskās farmakodinamikas nozīme zāļu izstrādē|Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://lv.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81182740.html Intranazālā ievadīšana dzīvnieku pētījumos https://lv.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://lv.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79443750.html Revolūcijas CNS zāļu izstrāde: PRISYS Biotech ievieš IMRI tehnoloģiju https://lv.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://lv.prisysbiotech.com/news/convection-enhanced-delivery-81182736.html Precīzās medicīnas attīstība: konvekcijas{0}}uzlabotās piegādes (CED) tehnoloģija, ko piedāvā Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://lv.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81182735.html Cynomolgus pērtiķu hroniskas nieru slimības (HNS) modelis Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://lv.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79538818.html Acu zāļu ievadīšanas neklīniskais drošības novērtējums, izmantojot Cynomolgus Macaques https://lv.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://lv.prisysbiotech.com/news/compartment-pk-model-81182746.html Izpratne par nodalījumu un bez{0}}nodalījumu modeļiem farmakokinētikā https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81182741.html Uzlabotas CNS piegādes metodes Cynomolgus pērtiķiem: oligonukleotīdu zāļu izstrādes paātrināšana https://lv.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://lv.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79538821.html Primātu, kas nav cilvēkveidīgie primāti, izmantošanas samazināšana neklīniskajos drošības novērtējumos: FDA un nozares perspektīvas https://lv.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://lv.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79538864.html LNP{0}}bāzētu gēnu terapijas zāļu LCMS preklīniskā bioanalīze https://lv.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://lv.prisysbiotech.com/news/mrna-based-therapies-past-79538854.html Uz MRNA{0}} balstītas terapijas: pagātne https://lv.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://lv.prisysbiotech.com/news/pk-strategies-of-pdc-79538861.html Peptīdu{0}}zāļu konjugātu (PDC) farmakokinētiskās izpētes stratēģijas https://lv.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://lv.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79538838.html AAV loma gēnu terapijā: imūnās atbildes reakcijas un toksicitāte https://lv.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://lv.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79538826.html Optimizētas neklīniskās imunogenitātes novērtēšanas stratēģijas https://lv.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://lv.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79538844.html Gēnu terapijas farmakodinamiskais (PD) novērtējums https://lv.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://lv.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79538846.html Oligonukleotīdu zāļu farmakokinētika un bioanalīze-(1) https://lv.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://lv.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79539444.html Oligonukleotīdu zāļu farmakokinētika un bioanalīze: absorbcijas un plazmas farmakokinētikas (PK) raksturojums https://lv.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://lv.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79538857.html Faktori, kas jāņem vērā, lai noteiktu oligonukleotīdu zāļu imunogenitāti https://lv.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://lv.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79538866.html MRNA: spēcīgs un daudzpusīgs rīks slimību apkarošanai-Prisys-Biotech https://lv.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://lv.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79538848.html Ķīniešu zinātnieki piedāvā jaunas stratēģijas Parkinsona slimības galveno simptomu mainīšanai https://lv.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://lv.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79538845.html Prisys Biotechnology: jaunas lipīdu nanodaļiņas MRNS piegādei primātiem https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79538843.html Translācijas medicīnas pētījumu nozīme no pamata pētījumiem līdz klīniskiem pētījumiem https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79538855.html Galvenie WOE analīzē ņemtie faktori https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79538847.html Kā nogādāt bioloģiskos līdzekļus smadzenēs? https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79539443.html Kā narkotikas pārvietojas un mainās mūsu organismā: īss ievads farmakokinētikā https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79538851.html Kā ātrāk un drošāk izstrādāt jaunas zāles: ceļvedis preklīniskajiem DMPK pētījumiem https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79538856.html Grupas izmitināšanas vadlīnijas laboratorijas pērtiķiem https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79538837.html Eksperimentālo pērtiķu svarīgā loma zinātniskās pētniecības attīstībā https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79538860.html Izpratne par Macaca Fascicularis (Cynomolgus Monkey): galvenās īpašības un ieguldījums biomedicīnas pētījumos https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79538834.html Revolūcija vielmaiņas slimību ārstēšanā: sasniegumi un izaicinājumi peptīdu zāļu izstrādē https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79539442.html Kā novērtēt ādas produktu drošību pirms klīniskajiem izmēģinājumiem? https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79538862.html Eksperimentālo pērtiķu nozīmīgā loma novatorisku zāļu izstrādē: ieskats biznesā https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79538850.html Aknu toksicitāte kā galvenā problēma SiRNA narkotikām: visaptverošas analīzes mērķa specifika: SiRNS abpusējs{0}}zobens https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79538831.html SiRNA terapijas attīstība: zāļu attīstības problēmu pārvarēšana https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79538832.html Uz lipīdu nanodaļiņām balstītu gēnu zāļu lietošanas perspektīvas https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79538835.html Galvenie punkti, izstrādājot stratēģiju ne{0}}neklīniskiem pētījumiem par nepilngadīgiem dzīvniekiem https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79538840.html Ieskats primātu (primātu, kas nav cilvēkveidīgie primāti) maņu un uzvedības iezīmēs https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79538859.html Neklīniskā pētījuma novērtējuma jautājumi un atbildes https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/significance-principles-and-requirements-of-79538865.html Drošības farmakoloģijas pētījumu nozīme, principi un prasības https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79538830.html Kā novērtēt preklīnisko farmakoloģisko efektivitāti? https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79538825.html Pārdomas par ne-klīniskās farmakoloģijas pētījumiem un bezalkoholiskā steatohepatīta (NASH) terapeitisko zāļu novērtēšanu https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79538822.html CNS un CGT pētniecības attīstība: Prisys biotehnoloģijas https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79538833.html Primātiem, kas nav cilvēkprimāti, cerebrospinālā šķidruma savākšanas vadlīnijas https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79538829.html Apsvērumi, interpretējot klīniskās patoloģijas datus primātiem, kas nav{0}}cilvēki primāti (NHP) un suņi https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79538819.html CNS drošības novērtējuma iekļaušana vispārējās toksikoloģijas pētījumos https://lv.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://lv.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79538841.html Kā veikt ADC preklīniskās farmakoloģijas/toksikoloģijas novērtēšanu? https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79538828.html ADME ieskats oligonukleotīdu zālēm (1) - Absorbcija, izplatīšana https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79538836.html ADME ieskats oligonukleotīdu zālēm (2) - Metabolisms un ekskrēcija https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79538810.html Preklīniskie pētījumi ar dzīvniekiem (1) - Dzīvnieku sugas https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79538823.html Klīniskās patoloģijas datu interpretācijas izaicinājumi un stratēģijas suņu un primātu, kas nav{0}}cilvēki, preklīniskajos pētījumos https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79538842.html Preklīniskie pētījumi ar dzīvniekiem (2) - ievadīšanas veidi un apjomi https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/mrna-based-therapies-present-79540318.html Uz MRNA{0}} balstītas terapijas: tagad https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79538863.html Uz MRNA{0}} balstītas terapijas: nākotne un izaicinājumi https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79538853.html Īss ievads par gēnu terapijas bioloģisko analīzi https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79443747.html Cynomolgus mērkaķis oftalmoloģisko zāļu izpētē https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79443751.html Translācijas un krusteniski{0}}Reaktīvie pētījumi ar Prisys NHP imunoloģijas un iekaisuma modeļiem https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79201184.html Ne{0}}Naivi NHP preklīniskajos pētījumos: izmaksu{1}}efektīvs risinājums, ko piedāvā Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/nhp-asthma-model-79201183.html NHP astmas modelis: Preklīnisko zāļu efektivitātes pētījumu veicināšana ar Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79201186.html Imunoloģijas un iekaisuma pētījumu uzlabošana ar Cynomolgus Macaques modeļiem - Prisys Biotechnologies https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79202395.html Tieša oligonukleotīdu zāļu piegāde CNS un biežas histopatoloģiskas izmaiņas https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79201187.html Prisys Biotech intra-cerebrovaskulāra insulta (ICH) modelis https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75175023.html Neklīniskie farmakodinamikas pētījumi: būtisks aspekts SiRNA zāļu izstrādē https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77736603.html MRI{0}}Lielo dzīvnieku centrālās nervu sistēmas precīza lokalizācijas un piegādes sistēma ir izveidota Prisys Biotech https://lv.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://lv.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77066365.html Inovatīvi risinājumi elpceļu terapijas uzlabošanai https://lv.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://lv.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74805059.html Prisys: Eksperimentu ar dzīvniekiem veicināšana, izmantojot Cynomolgus makaku pētījumus https://lv.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://lv.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76184107.html Prisys iegūst pilnu AAALAC International akreditāciju: pagrieziena punkts augstu laboratorijas dzīvnieku aprūpes standartu nodrošināšanā. https://lv.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://lv.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74682709.html Nukleīnskābju terapijas paaugstināšana, izmantojot visprogresīvākās priekšrocības, izmantojot Prisys Biotech primātu modeļus, kas nav cilvēkveidīgie primātu modeļi https://lv.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://lv.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74180215.html Revolucionāra CNS zāļu piegāde: Prisys un solījums veikt intratekālu injekciju https://img01.v15cdn.com/gallery/4x3/148.webp https://lv.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75174224.html Prisys Biotech 2024. gada 1. ceturkšņa biļetens - jūsu uzticamais primātu pētījumu speciālists https://lv.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://lv.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73594011.html Kā ar ultraskaņu{0}}vadīta aknu biopsija uzlabo makaka-izpēti https://lv.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://lv.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73594012.html Vadlīnijas primātu, kas nav cilvēkveidīgie primāti, izmantošanai biomedicīnas pētījumos: Prisys biotehnoloģijas perspektīva https://lv.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://lv.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73023955.html Primāti, kas nav-cilvēki: īss ievads par to bioloģiskajām īpašībām https://lv.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://lv.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72691470.html Izstādes apskats|Prisys Biotech spīd Amerikas Neiroloģijas biedrības ikgadējā sanāksmē (SfN 2023) https://lv.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://lv.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72323303.html Iepazīstieties ar Prisys Biotech Neiroloģijas biedrības ikgadējā sanāksmē (SfN 2023) https://lv.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://lv.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72322071.html Pasaules insulta diena|Koncentrējieties uz išēmisku insultu dzīvnieku modeļiem un farmakoloģiju https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72322070.html Prisys Biotech aicina jūs apmeklēt SAPA un Ķīnas ikgadējo sanāksmi 2023. https://lv.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://lv.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72322072.html Pasaules Alcheimera diena|Izaicinājumi un risinājumi AD zāļu izstrādei https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72323302.html Prisys Biotech Cynomolgus makaka dzīvnieku modelis palīdz izstrādāt jaunas antikoagulantu zāles https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71002296.html Prisys: augstas kvalitātes-dzīvnieku eksperimentu pakalpojuma nodrošināšana jaunajai anti-koagulācijas faktora XI antivielai BJTJ-1837 https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71005949.html Metode Cynomolgus pērtiķu hipertrigliceridēmijas modeļa izveidei un tās pielietošana https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71003724.html Farmakoloģija: galvenie parametri un farmakokinētikas (PK) nozīme https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71004561.html Onkolītisko vīrusu zāļu preklīniskās farmakoloģijas novērtējums https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/0-71006373.html Kā mazas nukleīnskābju zāles var pārveidot CNS slimību ārstēšanu: ieskats no Prisys Biotechnology, NHP slimību modeļu nodrošinātāja https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71002304.html Peptīdu zāļu farmakokinētika, pētniecības stratēģijas un gadījumu izpēte https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69664108.html Galvenie ADC narkotiku PK izpētes punkti https://img01.v15cdn.com/gallery/4x3/148.webp https://lv.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69668894.html Prisys Biotechnology: NHP CNS slimību modelēšanas pētniecības platformas līderis https://lv.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://lv.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309410.html Kā zaudēt svaru un kontrolēt diabētu, izmantojot GLP-1 produktus https://lv.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://lv.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309366.html Kā Ķīnas mērkaķis palīdz veikt pirmsklīnisko pētījumu efektivitāti? https://lv.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://lv.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309345.html Kāda ir RNSi efektivitāte? https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309392.html Prisys Biotech lielo dzīvnieku eksperimentu sabiedriskā pakalpojuma platforma: zemas-izmaksas un augstas{1}}efektivitātes risinājums eksperimentiem ar lieliem dzīvniekiem https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69039794.html Kā AAV gēnu terapija var glābt jūsu redzējumu: jaunākie sasniegumi, kas iegūti, veicot pētījumus, kas nav{0}}cilvēki primāti https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69029815.html Prisys Biotech Japānas Toksikoloģijas biedrības ikgadējā sanāksmē demonstrē ne{0}}cilvēku primātu modeļu platformu https://lv.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://lv.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69028481.html AAV gēnu terapijas daudzsološā nākotne{0}}primātiem, kas nav cilvēkveidīgie primāti https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69030382.html Kas ir lipīdu nanodaļiņas gēnu terapijai? https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69029743.html Prisys Biotech aicina jūs piedalīties Japānas Toksikoloģijas biedrības (JSOT) 50. gadskārtējā sanāksmē https://lv.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://lv.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69032378.html Imūntoksicitātes tests, zāļu drošības novērtējums{0}}PRISYS BIOTECH https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68327239.html Optimāls išēmiska insulta dzīvnieku modelis, kas izveidots ar digitālās atņemšanas angiogrāfiju{0}}vadīti autologi trombi Cynomolgus pērtiķiem https://lv.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://lv.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68121724.html Kāpēc jums vajadzētu rūpēties par primātiem, kas nav{0}}cilvēki primāti, nukleīnskābju zāļu piegādes sistēmas izpētē un attīstībā https://lv.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://lv.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68121722.html Iepazīstieties ar Prisys Biotech 70. gada pasākumā JALAS 2023! https://lv.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://lv.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68121725.html Gēnu terapija spīd ar jauniem reto slimību apstiprinājumiem https://lv.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://lv.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68121720.html Revolucionāra narkotiku atklāšana: kā primāti, kas nav cilvēkveidīgie primāti, optimizē SiRNS skrīningu, lai iegūtu ātrākus un efektīvākus rezultātus https://lv.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://lv.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67576455.html SiRNA farmakoloģijas efektivitātes palielināšana ar primātu izpēti, kas nav cilvēkveidīgie primāti https://lv.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://lv.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67570798.html Kā primāti, kas nav cilvēkveidīgie primāti, var revolucionizēt SiRNA izpēti: visaptverošs ceļvedis https://lv.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://lv.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67559001.html Pasaules laboratorijas dzīvnieku dienas atzīmēšana: kāpēc Prisys ir apņēmies veicināt primātu, kas nav cilvēkveidīgie primāti, veselību https://lv.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://lv.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67572680.html CRISPR/Cas9 pētniecības efektivitātes maksimāla palielināšana, izmantojot primātu modeļus, kas nav cilvēkveidīgie primāti https://lv.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://lv.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67552147.html Terapeitiskā potenciāla atraisīšana: kāpēc ieguldījumi nukleīnskābju medikamentos ir medicīnas nākotne https://lv.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://lv.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67559004.html Primātu, kas nav cilvēkveidīgie primāti, potenciāla atraisīšana, uzlabojot gēnu terapijas zāļu mērķa atklāšanu https://lv.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://lv.prisysbiotech.com/news/world-parkinsons-disease-day-67545500.html Apvienojieties par Parkinsona slimību: sadodamies rokās, lai palielinātu izpratni Pasaules Parkinsona slimības dienā https://lv.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://lv.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67545501.html Kā gēnu terapijas drošības novērtēšanā efektīvi izmantot primātus, kas nav cilvēkveidīgie primāti https://lv.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://lv.prisysbiotech.com/news/gene-therapy-toxicology-66274546.html Gēnu terapijas toksikoloģijas pētījumi ar Nonhuam primātu https://lv.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://lv.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66139155.html Visaptveroša rokasgrāmata DMPK pētījuma veikšanai gēnu terapijai https://lv.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://lv.prisysbiotech.com/news/gene-therapy-nhp-model-66139147.html Revolucionāri medicīnas pētījumi: gēnu terapijas sasniegumi primātu slimību modeļos, kas nav cilvēkveidīgie primāti! https://lv.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://lv.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66139149.html 10 populārākie jautājumi, kas saistīti ar gēnu terapiju https://lv.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://lv.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66139150.html Prisys Biotech: Ne{0}}cilvēku primātu farmakoloģija gēnu terapijai https://lv.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://lv.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66139144.html Atbalsts sieviešu veselībai: ieskats endometriozes jomā https://lv.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://lv.prisysbiotech.com/news/prisys-sot2023-66139148.html PRISYS un Taichu Group sadarbojas SOT izstādē 2023. gadā https://lv.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://lv.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66274544.html Vai mums ir nepieciešami papildu pētījumi sāpju novērtēšanai? - NHP https://lv.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://lv.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66139146.html Pievienojieties mums, lai atzīmētu Pasaules savvaļas dzīvnieku dienu https://lv.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://lv.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66139145.html Prisys Shanghai NHP pētniecības un attīstības centrs sāk darbu, iezīmējot pavērsienu farmācijas pētniecībā un attīstībā Ķīnā https://lv.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://lv.prisysbiotech.com/news/meetprisys-sot2023-66274543.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://lv.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg